Dementia: epidemiology, clinical picture, diagnosis, approaches to therapy
https://doi.org/10.14412/2074-2711-2013-2459
Abstract
The review of literature discusses in detail the clinical signs of non-dementia cognitive impairments (CIs) and differences between subclinical, mild, and moderate CIs. It considers in detail the manifestations of dementia, the typical clinical picture of the most common forms of dementia, such as Alzheimer’s disease, Lewy body dementia, and vascular dementia. The paper outlines basic approaches to the pathogenetic therapy for dementia and the efficiency and safety of using NMDA receptor antagonists in patients with this pathology.
About the Author
Irina Sergeyevna Preobrazhenskaya
Department of Nervous System Diseases, Faculty of Therapeutics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
References
1. <div><p>Захаров ВВ, Яхно НН. Синдром умеренных КН в пожилом возрасте – диагностика и лечение. Русский медицинский журнал. 2004;(10):573–6. [Zakharov VV, Yakhno NN. Sindrom umerennykh KN v pozhilom vozraste – diagnostika i lechenie. Russkiy meditsinskiy zhurnal. 2004;(10):573–6.]</p><p>Гаврилова СИ. Мягкое когнитивное снижение - доклиническая стадия болезни Альцгеймера? Consilium Medicum. 2004;(2):153–6. [Gavrilova SI. Myagkoe kognitivnoe snizhenie - doklinicheskaya stadiya bolezni Al'tsgeymera? Consilium Medicum. 2004;(2):153–6.]</p><p>Galasko D. New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future. Clin Geriatr Med. 2001;17(2):393–410.</p><p>Petersen RC. Mild cognitive impairment as a diagnostic entity. J Int Med. 2004;256(3):183–94. DOI: http://dx.doi.org/10.1111%2Fj.1365-2796.2004.01388.x.</p><p>Waldemar G, Phung KT, Burns A et al. Access to diagnostic evaluation and treatment for dementia in Europe. Int J Geriatr Psychiatry. 2007;22(1):47–54. DOI: http://dx.doi.org/10.1002%2Fgps.1652.</p><p>Small BJ, Fratiglioni L, Vitanen M et al. Time course of preclinical coginitive deficits in Alzheimer’s disease. In: Research and practice in Alzheimer's disease. Paris: Serdi Publisher; 2001;5:29–34.</p><p>Brookmeyer R, Johnson E, Ziegler-Graham K et al. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3(3):168–9. DOI: http://dx.doi.org/10.1016%2Fj.jalz.2007.04.381.</p><p>Braak H, Braak E. Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett. 1987;76(1):124–7. DOI: http://dx.doi.org/10.1016%2F0304-3940%2887%2990204-7.</p><p>Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimers disease. Lancet. 1976;2(8000):1403. DOI: http://dx.doi.org/10.1016%2FS0140-6736%2876%2991936-X.</p><p>Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer's disease. Lancet Neurol. 2004;3(4):246–8. DOI: http://dx.doi.org/10.1016%2FS1474-4422%2804%2900710-0.</p><p>Преображенская ИС. Деменция с тельцами Леви. Дис. … докт. мед. наук. Москва; 2005. 367 с. [Preobrazhenskaya IS. Dementsiya s tel'tsami Levi. Dis. … dokt. med. nauk. Moskva; 2005. 367 p.]</p><p>Яхно НН, Преображенская ИС. Деменция с тельцами Леви. Неврологический журнал. 2003;8(6):4–12. [Yakhno NN, Preobrazhenskaya IS. Dementia with Lewy bodies. Nevrologicheskiy zhurnal. 2003;8(6):4–12.]</p><p>Gnanalingham КК, Byrne EJ, Thornton A et al. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62(3):243–52. DOI: http://dx.doi.org/10.1136%2Fjnnp.62.3.243.</p><p>McKeith IG, Ballard CG, Perry RH et al. Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 2001;54(5):1050–8. DOI: http://dx.doi.org/10.1212%2FWNL.54.5.1050.</p><p>Парфенов ВА. Артериальная гипертония и инсульт. Неврологический журнал. 2001;(6):4–7. [Parfenov VA. Arterial'naya gipertoniya i insul't. Nevrologicheskiy zhurnal. 2001;(6):4–7.]</p><p>Парфенов ВА, Вахнина НВ. Артериальная гипертония и гипотензивная терапия при ишемическом инсульте. Неврологический журнал. 2001;(4):19–22. [Parfenov VA, Vakhnina NV. Arterial'naya gipertoniya i gipotenzivnaya terapiya pri ishemicheskom insul'te. Nevrologicheskiy zhurnal. 2001;(4):19–22.]</p><p>Danysz W, Parsons CG, Mobius HJ et al. Neuroprotective and synptomatological action of memantine relevant for Alzheimer’s disease – A unified glutamatergic hypothesis on the mechanism of action. Neurotox Res. 2000;2(2–3):85–97. DOI: http://dx.doi.org/10.1007%2FBF03033787.</p><p>Knopman DS. Current treatement of mild cognitive impairement an Alzheimer’s disesase. Curr Neurol Neurosci Rep. 2006:6(5):365–71. DOI: http://dx.doi.org/10.1007%2Fs11910-996-0016-9.</p></div><br />
Review
For citations:
Preobrazhenskaya IS. Dementia: epidemiology, clinical picture, diagnosis, approaches to therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2013;5(4):71-77. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2459
Views:
1444
Email this article 